| First Author | Fog CK | Year | 2015 |
| Journal | Blood | Volume | 125 |
| Issue | 8 | Pages | 1272-81 |
| PubMed ID | 25499759 | Mgi Jnum | J:221379 |
| Mgi Id | MGI:5638990 | Doi | 10.1182/blood-2014-03-560805 |
| Citation | Fog CK, et al. (2015) Loss of PRDM11 promotes MYC-driven lymphomagenesis. Blood 125(8):1272-81 |
| abstractText | The PR-domain (PRDM) family of genes encodes transcriptional regulators, several of which are deregulated in cancer. By using a functional screening approach, we sought to identify novel tumor suppressors among the PRDMs. Here we demonstrate oncogenic collaboration between depletion of the previously uncharacterized PR-domain family member Prdm11 and overexpression of MYC. Overexpression of PRDM11 inhibits proliferation and induces apoptosis. Prdm11 knockout mice are viable, and loss of Prdm11 accelerates MYC-driven lymphomagenesis in the Emicro-Myc mouse model. Moreover, we show that patients with PRDM11-deficient diffuse large B-cell lymphomas (DLBCLs) have poorer overall survival and belong to the nongerminal center B-cell-like subtype. Mechanistically, genome-wide mapping of PRDM11 binding sites coupled with transcriptome sequencing in human DLBCL cells evidenced that PRDM11 associates with transcriptional start sites of target genes and regulates important oncogenes such as FOS and JUN. Hence, we characterize PRDM11 as a putative novel tumor suppressor that controls the expression of key oncogenes, and we add new mechanistic insight into B-cell lymphomagenesis. |
